Lidoderm

Holveck's strategy is to transform itself from a specialty pharmaceutical maker focused on pain management medicines such as Lidoderm and Percocet to one that provides an array of diagnostic tools, medical devices and therapeutic compounds that promote pelvic health.

Dallas Business News - Local Dallas News | Dallas Business Journal 2009

Holveck's strategy is to transform itself from a specialty pharmaceutical maker focused on pain management medicines such as Lidoderm and Percocet to one that provides an array of diagnostic tools, medical devices and therapeutic compounds that promote pelvic health.

San Antonio Business News - Local San Antonio News | The San Antonio Business Journal 2009

Holveck's strategy is to transform itself from a specialty pharmaceutical maker focused on pain management medicines such as Lidoderm and Percocet to one that provides an array of diagnostic tools, medical devices and therapeutic compounds that promote pelvic health.

National Business News - Local Business News | bizjournals 2009

That is down from a 61% contribution a couple years earlier as Endo worked to diversify the business; after acquiring AMS, Lidoderm will account for less than 30% of sales, officials said.

Endo Diversifies in Urology Deal Jon Kamp 2011

Endo, based in Chadds Ford, Pa., posted total sales of $1.72 billion last year, with its pain patch Lidoderm contributing about 46% of that total.

Endo Diversifies in Urology Deal Jon Kamp 2011

Endo has historically relied heavily on pain drugs, and its Lidoderm pain patch in particular, but has pursued deals to lessen that reliance and branch out into medical devices.

Endo Diversifies in Urology Deal Jon Kamp 2011

The company is dependent on Lidoderm for 62% of sales.

Good Thoughts Lauren R. Rublin 2009

Lidoderm is a topical treatment for post-shingles neuralgia.

Good Thoughts Lauren R. Rublin 2009

Endo is known for Lidoderm, a treatment for post-shingles pain and DepoDur, which is used to treat pain after a major surgery.

Endo Will Buy Indevus in $637 Million Deal 2009

Net sales of Lidoderm, the company's treatment for post-shingles pain, rose 20%, while pain treatment Percocet posted a 10% sales gain.

War and Cease 2008